Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UG3DA058305-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.
A four-week feasibility trial of the CC app with a sample individuals on probation and parole with SUDs who are receiving outpatient substance use disorder treatment will be recruited and use the app for 12 weeks during community treatment. Study participants will complete brief questionnaires at study initiation (focusing on background characteristics, treatment history, app expectations) and after the 4-week feasibility trial (focusing on their experiences with the app, usability, satisfaction, and suggestions for improvement).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| continuing care app | Experimental | continuing care app through a mobile cell phone |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| continuing care app | Device | continuing care app is an app on a smartphone |
|
| Measure | Description | Time Frame |
|---|---|---|
| app usability | Questions about usability will be asked using the System Usability Scale (SUS), one of the most widely used standardized measures to assess technology usability. Using this scale, participants are asked to provide a score for 10-items, using 5-point Likert scales, regarding: a) ease of use, and b) learnability. | 12 weeks post baseline |
| Feasibility and Satisfaction Survey | Feasibility and Satisfaction Survey (FSS) that was developed and used in our prior research and will be used to assesses feasibility and satisfaction. Questions will consist of 5-point Likert scales and open-ended questions focused on: 1) program utilization [frequency of reviewing app content], 2) overall look, feel, and experience, 3) ease of use, and 4) app content/tools (i.e., relevance, usefulness, and engagement). | 12-weeks post-baseline |
Not provided
Not provided
Inclusion Criteria:
1) age 18 or older, 2) currently on probation or parole, 3) currently a client receiving outpatient substance use treatment at one of the three participating clinics, 4) willing to receive supplemental treatment services through a mobile app, and 5) willing to provide informed consent and complete research assessments
Exclusion Criteria:
1) Active medical history that may preclude participation (e.g., requires higher level of care; active psychosis; compromised comprehension)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael S Gordon, DPA | Friends Research Institute, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Friends Research Institute | Baltimore | Maryland | 21201-5633 | United States |
The data is needed for a larger phase submission.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
continuing care app
Not provided
Not provided
Not provided
Not provided